BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 27633450)

  • 1. Application of a predictive model of axillary lymph node status in patients with sentinel node metastasis from breast cancer. A retrospective cohort study.
    Vieni S; Graceffa G; La Mendola R; Latteri S; Cordova A; Latteri MA; Cipolla C
    Int J Surg; 2016 Nov; 35():58-63. PubMed ID: 27633450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
    Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
    Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of an existing and modified model for predicting non sentinel lymph node metastasis in breast cancer patients with positive sentinel node biopsy.
    Al-Masri M; Darwazeh G; El-Ghanem M; Hamdan B; Sughayer M
    Gulf J Oncolog; 2013 Jan; 1(13):15-22. PubMed ID: 23339977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary lymph node dissection in the case of sentinel lymph node micrometastatic invasion: evaluation of three predictive models.
    Orsoni M; Clerc J; Golfier F; Cortet M; Raudrant D; Krauth JS
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):334-7. PubMed ID: 21669485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
    Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
    Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?
    Madekivi V; Boström P; Karlsson A; Aaltonen R; Salminen E
    Acta Oncol; 2020 Jun; 59(6):689-695. PubMed ID: 32148141
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
    Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
    Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
    van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
    Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An independent assessment of the 7 nomograms for predicting the probability of additional axillary nodal metastases after positive sentinel lymph node biopsy in a cohort of British patients with breast cancer.
    Nadeem RM; Gudur LD; Saidan ZA
    Clin Breast Cancer; 2014 Aug; 14(4):272-9. PubMed ID: 25037530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.
    Ryu JM; Lee SK; Kim JY; Yu J; Kim SW; Lee JE; Han SH; Jung YS; Nam SJ
    Clin Breast Cancer; 2017 Nov; 17(7):550-558. PubMed ID: 28454926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node].
    Huang J; Chen X; Fei X; Huang O; Wu J; Zong Y; Zhu L; He J; Chen W; Li Y; Shen K
    Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):941-6. PubMed ID: 26850667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
    Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
    Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer Surgery.
    Ahn SK; Kim MK; Kim J; Lee E; Yoo TK; Lee HB; Kang YJ; Kim J; Moon HG; Chang JM; Cho N; Moon WK; Park IA; Noh DY; Han W
    Cancer Res Treat; 2017 Oct; 49(4):1088-1096. PubMed ID: 28161935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
    Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
    Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients.
    Sasada T; Kataoka T; Shigematsu H; Masumoto N; Kadoya T; Okada M; Ohdan H
    Breast Cancer; 2014 Sep; 21(5):571-5. PubMed ID: 23307473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of four published risk models to predict sentinel lymph-node involvement in Australian women with early breast cancer.
    Elmadahm A; Lord SJ; Hudson HM; Lee CK; Buizen L; Farshid G; Gebski VJ; Gill PG
    Breast; 2018 Oct; 41():82-88. PubMed ID: 30007272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.
    Sa-Nguanraksa D; O-Charoenrat E; Kulprom A; Samarnthai N; Lohsiriwat V; Nimpoonsri K; O-Charoenrat P
    Breast Cancer; 2019 Jul; 26(4):471-477. PubMed ID: 30617675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.